Archive for the ‘Trasylol’ Category
Lawsuit filed against Bayer Pharmaceuticals
A West Virginia man filed a federal lawsuit against Bayer in which he alleges he was not warned of the potential side effects of Trasylol prior to his coronary artery bypass surgery. As a result, the plaintiff suffers from acute renal failure.
Trasylol is commonly used to control bleeding in heart surgeries. [...]
November 30, 2009
Tags: Bayer Pharmaceuticals, birth control, FDA, renal failure Posted in: Trasylol 
No Comments
Trasylol linked to 1,000 deaths per month
Trasylol, a drug used in one third of all cardiac bypass operations to control bleeding, was on the market for 14 years, possibly contributing to thousands of deaths. Why did it take Bayer Pharmaceuticals and the FDA 2 years to take the drug off the market? At the height of the drug’s use, [...]
November 30, 2009
Tags: Bayer Pharmaceuticals, FDA, side effects Posted in: Trasylol 4 Comments
Risk of kidney failure high for Trasylol users
Trasylol, generically called Aprotinin, is a protease inhibitor used to reduce perioperative blood loss and the need for blood transfusions in patients undergoing heart bypass surgery.
Recent studies have found that Trasylol significantly increases the risk of kidney failure, stroke and heart failure or heart attack by up to 55 percent. A recent study, published [...]
November 19, 2009
Tags: kidney failure, side effects, Trasylol Posted in: Trasylol No Comments